MacroGenics | MGNX - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
AbbVie USD 1.77B 608K 2026-06
Amgen USD 541M 0 2026-09
AstraZeneca USD 1.55B 28K 2026-09
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Daiichi Sankyo JPY 1.82B 1.68M 2026-09
Eli Lilly USD 943.5M 3.33M 2026-03
Genmab DKK 61.44M 181K 2026-06
Geron USD 640.9M 2.54M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
J&J USD 2.41B 1.64M 2026-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
MacroGenics USD 63.65M 86K 2026-06
Merck USD 2.47B 1.05M 2026-06
Pfizer USD 5.7B 1000K 2026-09
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Xencor USD 74.33M 265K 2026-06